New hope for rare scalp disease: biologics aim to stop painful flares and hair loss

NCT ID NCT07268534

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests biologic drugs for folliculitis decalvans, a rare scalp disease that causes painful pustules and permanent hair loss. Current antibiotics only work about half the time and the condition often returns. The trial will enroll 120 adults who have already tried at least two antibiotic treatments, and will measure if biologics can reduce disease severity over 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOLLICULITIS DECALVANS (FD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.